GO Term |
GO Name |
Enriched Genes |
Log10 Adjusted P-value |
[BP] GO:0015701 |
bicarbonate transport
|
CA1, CA12, CA14, CA2, CA4, CA5A, CA5B, CA6, CA7, CA9 |
11.8826 |
[BP] GO:0006730 |
one-carbon metabolic process
|
CA1, CA12, CA2, CA4, CA5A, CA5B, CA6, CA7, CA9 |
11.0669 |
[BP] GO:0010647 |
positive regulation of cell communication
|
ADORA1, ADRA2A, ADRA2C, AKR1B1, ALOX15, AXL, CA2, CA7, CSNK2A1, CYP19A1, CYP1B1, DRD2, DRD3, DRD4, EGFR, F10, FLT3, GPR35, HCAR2, HSPA1A, INSR, KDR, MET, MMP12, MMP9, SMAD3, SRC, TEK, XDH |
10.4088 |
[BP] GO:0023056 |
positive regulation of signaling
|
ADORA1, ADRA2A, ADRA2C, AKR1B1, ALOX15, AXL, CA2, CA7, CSNK2A1, CYP19A1, CYP1B1, DRD2, DRD3, DRD4, EGFR, F10, FLT3, GPR35, HCAR2, HSPA1A, INSR, KDR, MET, MMP12, MMP9, SMAD3, SRC, TEK, XDH |
10.4069 |
[BP] GO:0065008 |
regulation of biological quality
|
ACHE, ADORA1, ADRA2A, ADRA2C, AKR1B1, ALOX15, APEX1, AURKB, AXL, CA12, CA2, CA7, CYP19A1, CYP1A1, CYP1B1, DRD2, DRD3, DRD4, EGFR, EPHX2, F10, FABP3, FABP4, FLT3, GPR35, HCAR2, HSD17B1, HSD17B2, HSPA1A, INSR, KDR, MET, PPARA, SLC6A2, SLC6A3, SMAD3, SRC, TEK, XDH |
10.2057 |
[BP] GO:0010033 |
response to organic substance
|
ADRA2A, AKR1B1, ALOX15, APEX1, AXL, CA2, CA9, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, DRD2, DRD3, DRD4, EGFR, EPHX1, FABP3, FABP4, FLT3, HSD17B2, HSPA1A, IGF1R, INSR, KDR, MMP2, PPARA, SLC6A3, SMAD3, SRC, TEK, TYR |
10.1408 |
[BP] GO:0042221 |
response to chemical
|
ADRA2A, AKR1B1, ALOX15, APEX1, AXL, CA2, CA9, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, DRD2, DRD3, DRD4, EGFR, EPHX1, EPHX2, FABP3, FABP4, FLT3, HSD17B2, HSPA1A, IGF1R, INSR, KDR, MMP2, MMP9, PPARA, SLC6A2, SLC6A3, SMAD3, SRC, TEK, TYR |
10.1408 |
[BP] GO:0044281 |
small molecule metabolic process
|
AKR1B1, ALOX15, ALOX5, CA1, CA12, CA2, CA4, CA5A, CA5B, CA6, CA7, CA9, CBR1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, EPHX1, EPHX2, FABP3, FUT7, GLO1, HSPA1A, PIM1, PPARA, TYR, XDH |
10.1408 |
[BP] GO:0006629 |
lipid metabolic process
|
ACHE, ADORA1, AKR1B1, ALOX15, ALOX5, CBR1, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, DRD2, EGFR, EPHX2, FABP3, FABP4, FUT7, HSD17B1, HSD17B2, MET, PPARA |
8.21488 |
[BP] GO:0015711 |
organic anion transport
|
CA1, CA12, CA14, CA2, CA4, CA5A, CA5B, CA6, CA7, CA9, DRD2, DRD3, DRD4, FABP3, PPARA |
7.98039 |
[BP] GO:0009967 |
positive regulation of signal transduction
|
ADORA1, ADRA2A, ADRA2C, AKR1B1, ALOX15, AXL, CSNK2A1, CYP1B1, DRD2, DRD3, DRD4, EGFR, F10, FLT3, GPR35, HSPA1A, INSR, KDR, MET, MMP12, MMP9, SMAD3, SRC, TEK, XDH |
7.9669 |
[BP] GO:1902531 |
regulation of intracellular signal transduction
|
ADORA1, ADRA2A, ADRA2C, AKR1B1, ALOX15, AURKB, AXL, CSNK2A1, CYP1B1, DRD2, DRD3, DRD4, DUSP3, EGFR, F10, FLT3, GPR35, HSPA1A, IGF1R, INSR, KDR, MET, MMP9, NUAK1, SRC, TEK, XDH |
7.94247 |
[BP] GO:0019369 |
arachidonic acid metabolic process
|
ALOX15, CBR1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, EPHX2 |
7.94247 |
[BP] GO:0008152 |
metabolic process
|
ACHE, ADORA1, AKR1B1, ALOX15, ALOX5, APEX1, AURKB, AXL, CA1, CA12, CA2, CA4, CA5A, CA5B, CA6, CA7, CA9, CBR1, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, DRD2, DRD3, DRD4, DUSP3, EGFR, EPHX1, EPHX2, F10, FABP3, FABP4, FLT3, FUT7, GLO1, HSD17B1, HSD17B2, HSPA1A, IGF1R, INSR, KDR, MET, MMP1, MMP12, MMP2, MMP9, NUAK1, PIM1, PPARA, SLC6A3, SMAD3, SRC, TEK, TOP2A, TYR, XDH |
7.58721 |
[BP] GO:0010035 |
response to inorganic substance
|
AKR1B1, ALOX15, APEX1, AXL, CA2, CYP1A1, CYP1A2, CYP1B1, DRD2, EGFR, FABP4, KDR, MMP9, SLC6A3, SRC |
7.51572 |
[BP] GO:0033559 |
unsaturated fatty acid metabolic process
|
ALOX15, ALOX5, CBR1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, EPHX2 |
7.46802 |
[BP] GO:1902533 |
positive regulation of intracellular signal transduction
|
ADORA1, ADRA2A, ADRA2C, AKR1B1, ALOX15, AXL, CYP1B1, DRD2, DRD4, EGFR, F10, FLT3, GPR35, HSPA1A, INSR, KDR, MET, SRC, TEK, XDH |
7.4365 |
[BP] GO:0032879 |
regulation of localization
|
ACHE, ADORA1, ADORA3, ADRA2A, ADRA2C, ALOX15, APEX1, AXL, CA2, CA7, CSNK2A1, CYP19A1, CYP1B1, DRD2, DRD3, DRD4, EGFR, F10, GPR35, HCAR2, HSPA1A, IGF1R, INSR, KDR, MET, MMP12, MMP9, PPARA, SMAD3, SRC, TEK |
7.32149 |
[BP] GO:0019373 |
epoxygenase P450 pathway
|
CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, EPHX2 |
7.32149 |
[BP] GO:0006690 |
icosanoid metabolic process
|
ALOX15, ALOX5, CBR1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, EPHX2 |
7.26866 |
[BP] GO:1901700 |
response to oxygen-containing compound
|
AKR1B1, APEX1, AXL, CA9, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, DRD2, DRD3, EGFR, FABP3, HSD17B2, IGF1R, INSR, MMP2, MMP9, PPARA, SLC6A3, SRC, TEK, TYR |
7.11401 |
[BP] GO:0044237 |
cellular metabolic process
|
ACHE, AKR1B1, ALOX15, ALOX5, APEX1, AURKB, AXL, CA1, CA12, CA2, CA4, CA5A, CA5B, CA6, CA7, CA9, CBR1, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, DRD2, DRD3, DRD4, DUSP3, EGFR, EPHX1, EPHX2, F10, FABP3, FABP4, FLT3, FUT7, GLO1, HSD17B1, HSD17B2, HSPA1A, IGF1R, INSR, KDR, MET, MMP1, MMP2, NUAK1, PIM1, PPARA, SLC6A3, SMAD3, SRC, TEK, TOP2A, TYR, XDH |
7.02467 |
[BP] GO:0014070 |
response to organic cyclic compound
|
APEX1, CA2, CA9, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, DRD2, DRD3, DRD4, EGFR, EPHX1, FLT3, SLC6A3, SRC, TEK, TYR |
6.83742 |
[BP] GO:0050896 |
response to stimulus
|
ACHE, ADORA1, ADORA3, ADRA2A, AKR1B1, ALOX15, APEX1, AURKB, AXL, CA2, CA6, CA9, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, DRD2, DRD3, DRD4, EGFR, EPHX1, EPHX2, F10, FABP3, FABP4, FLT3, HSD17B2, HSPA1A, IGF1R, INSR, KDR, MMP12, MMP2, MMP9, NUAK1, PPARA, SLC6A2, SLC6A3, SMAD3, SRC, TEK, TOP2A, TYR |
6.82258 |
[BP] GO:0042127 |
regulation of cell proliferation
|
ADORA1, ADORA3, ADRA2A, AKR1B1, CSNK2A1, CYP1B1, DRD2, DRD3, EGFR, FABP3, FLT3, HSPA1A, IGF1R, INSR, KDR, MMP12, MMP2, MMP9, NUAK1, PIM1, SMAD3, SRC, TEK, XDH |
6.75786 |
[BP] GO:0010646 |
regulation of cell communication
|
ACHE, ADORA1, ADRA2A, ADRA2C, AKR1B1, ALOX15, AURKB, AXL, CA2, CA7, CSNK2A1, CYP19A1, CYP1B1, DRD2, DRD3, DRD4, DUSP3, EGFR, F10, FLT3, GPR35, HCAR2, HSPA1A, IGF1R, INSR, KDR, MET, MMP12, MMP9, NUAK1, SMAD3, SRC, TEK, XDH |
6.75786 |
[BP] GO:0006820 |
anion transport
|
CA1, CA12, CA14, CA2, CA4, CA5A, CA5B, CA6, CA7, CA9, DRD2, DRD3, DRD4, FABP3, PPARA |
6.73702 |
[BP] GO:0019748 |
secondary metabolic process
|
AKR1B1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, TYR |
6.66947 |
[BP] GO:0048518 |
positive regulation of biological process
|
ACHE, ADORA1, ADRA2A, ADRA2C, AKR1B1, ALOX15, APEX1, AURKB, AXL, CA2, CA7, CSNK2A1, CYP19A1, CYP1A1, CYP1B1, DRD2, DRD3, DRD4, DUSP3, EGFR, EPHX2, F10, FABP3, FABP4, FLT3, GPR35, HCAR2, HSPA1A, IGF1R, INSR, KDR, MET, MMP1, MMP12, MMP2, MMP9, PIM1, PPARA, SLC6A3, SMAD3, SRC, TEK, TOP2A, XDH |
6.65582 |
[BP] GO:0023051 |
regulation of signaling
|
ACHE, ADORA1, ADRA2A, ADRA2C, AKR1B1, ALOX15, AURKB, AXL, CA2, CA7, CSNK2A1, CYP19A1, CYP1B1, DRD2, DRD3, DRD4, DUSP3, EGFR, F10, FLT3, GPR35, HCAR2, HSPA1A, IGF1R, INSR, KDR, MET, MMP12, MMP9, NUAK1, SMAD3, SRC, TEK, XDH |
6.65582 |
[BP] GO:0048522 |
positive regulation of cellular process
|
ACHE, ADORA1, ADRA2A, ADRA2C, AKR1B1, ALOX15, APEX1, AURKB, AXL, CA2, CA7, CSNK2A1, CYP19A1, CYP1A1, CYP1B1, DRD2, DRD3, DRD4, DUSP3, EGFR, F10, FABP3, FLT3, GPR35, HCAR2, HSPA1A, IGF1R, INSR, KDR, MET, MMP1, MMP12, MMP2, MMP9, PIM1, PPARA, SMAD3, SRC, TEK, TOP2A, XDH |
6.55169 |
[BP] GO:0032501 |
multicellular organismal process
|
ADORA1, ADRA2A, ADRA2C, AKR1B1, ALOX15, ALOX5, AXL, CYP19A1, CYP1A2, CYP1B1, DRD2, DRD3, DRD4, DUSP3, EGFR, EPHX2, F10, FABP4, HSD17B2, IGF1R, INSR, MET, MMP1, MMP12, MMP2, MMP9, PIM1, PPARA, SLC6A2, SLC6A3, SMAD3, SRC, TEK, TYR |
6.55169 |
[BP] GO:0030334 |
regulation of cell migration
|
ADORA1, ADORA3, ADRA2A, APEX1, CYP19A1, CYP1B1, DRD2, EGFR, F10, IGF1R, INSR, KDR, MET, MMP9, SMAD3, SRC, TEK |
6.55169 |
[BP] GO:0048584 |
positive regulation of response to stimulus
|
ADORA1, ADRA2A, ADRA2C, AKR1B1, ALOX15, AXL, CSNK2A1, CYP1B1, DRD2, DRD3, DRD4, EGFR, F10, FABP4, FLT3, GPR35, HSPA1A, INSR, KDR, MET, MMP12, MMP2, MMP9, SMAD3, SRC, TEK, XDH |
6.5237 |
[BP] GO:0040012 |
regulation of locomotion
|
ADORA1, ADORA3, ADRA2A, APEX1, CYP19A1, CYP1B1, DRD2, DRD3, EGFR, F10, IGF1R, INSR, KDR, MET, MMP9, SMAD3, SRC, TEK |
6.5237 |
[BP] GO:0009636 |
response to toxic substance
|
AKR1B1, APEX1, AXL, CYP1A1, CYP1B1, DRD2, DRD3, DRD4, EPHX1, EPHX2, KDR, SLC6A3, SRC |
6.42115 |
[BP] GO:0046777 |
protein autophosphorylation
|
AURKB, CSNK2A1, EGFR, FLT3, IGF1R, INSR, KDR, PIM1, SRC, TEK |
6.28751 |
[BP] GO:2000145 |
regulation of cell motility
|
ADORA1, ADORA3, ADRA2A, APEX1, CYP19A1, CYP1B1, DRD2, EGFR, F10, IGF1R, INSR, KDR, MET, MMP9, SMAD3, SRC, TEK |
6.17552 |
[BP] GO:0001676 |
long-chain fatty acid metabolic process
|
ALOX15, CBR1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, EPHX2 |
6.13722 |
[BP] GO:0010941 |
regulation of cell death
|
ADORA1, AKR1B1, APEX1, AURKB, AXL, CSNK2A1, CYP1B1, EGFR, FLT3, GLO1, HCAR2, HSPA1A, IGF1R, KDR, MET, MMP9, PIM1, PPARA, SMAD3, SRC, TEK, TOP2A, XDH |
6.08462 |
[BP] GO:0017144 |
drug metabolic process
|
ACHE, AKR1B1, CBR1, CYP1A1, CYP1A2, CYP1B1, CYP2A6, DRD2, DRD3, DRD4, EGFR, EPHX2, HSPA1A, SLC6A3 |
6.03633 |
[BP] GO:0044255 |
cellular lipid metabolic process
|
ACHE, ALOX15, ALOX5, CBR1, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, DRD2, EGFR, EPHX2, FABP3, FABP4, FUT7, MET, PPARA |
6.03633 |
[BP] GO:0042592 |
homeostatic process
|
ADORA1, ADRA2A, AKR1B1, APEX1, AXL, CA12, CA2, CA7, DRD2, DRD3, DRD4, EGFR, EPHX2, FABP3, FABP4, FLT3, GPR35, INSR, MET, SMAD3, SRC |
6.03633 |
[BP] GO:0051896 |
regulation of protein kinase B signaling
|
AXL, DRD2, DRD3, EGFR, F10, INSR, MET, SRC, TEK, XDH |
6.03412 |
[BP] GO:1901568 |
fatty acid derivative metabolic process
|
ALOX15, ALOX5, CBR1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, EPHX2 |
5.98827 |
[BP] GO:0043067 |
regulation of programmed cell death
|
ADORA1, AKR1B1, APEX1, AURKB, AXL, CSNK2A1, CYP1B1, EGFR, FLT3, GLO1, HCAR2, HSPA1A, IGF1R, KDR, MET, MMP9, PIM1, SMAD3, SRC, TEK, TOP2A, XDH |
5.97263 |
[BP] GO:0010243 |
response to organonitrogen compound
|
AKR1B1, APEX1, DRD2, DRD3, DRD4, EGFR, FABP3, FLT3, IGF1R, INSR, MMP2, PPARA, SLC6A3, SRC, TEK, TYR |
5.85467 |
[BP] GO:0006631 |
fatty acid metabolic process
|
ALOX15, ALOX5, CBR1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, EPHX2, FABP3, PPARA |
5.79665 |
[BP] GO:0051270 |
regulation of cellular component movement
|
ADORA1, ADORA3, ADRA2A, APEX1, CYP19A1, CYP1B1, DRD2, EGFR, F10, IGF1R, INSR, KDR, MET, MMP9, SMAD3, SRC, TEK |
5.73551 |
[BP] GO:1901698 |
response to nitrogen compound
|
AKR1B1, APEX1, DRD2, DRD3, DRD4, EGFR, FABP3, FLT3, IGF1R, INSR, MMP2, PPARA, SLC6A3, SRC, TEK, TYR |
5.41481 |
[BP] GO:0018108 |
peptidyl-tyrosine phosphorylation
|
AXL, EGFR, FLT3, IGF1R, INSR, KDR, MET, SRC, TEK |
5.37006 |
[BP] GO:0060548 |
negative regulation of cell death
|
ADORA1, AKR1B1, AURKB, AXL, CSNK2A1, EGFR, GLO1, HSPA1A, IGF1R, KDR, MET, MMP9, PIM1, PPARA, SMAD3, SRC, TEK |
5.37006 |
[BP] GO:0042981 |
regulation of apoptotic process
|
ADORA1, AKR1B1, APEX1, AURKB, AXL, CSNK2A1, CYP1B1, EGFR, FLT3, GLO1, HCAR2, HSPA1A, IGF1R, KDR, MMP9, PIM1, SMAD3, SRC, TEK, TOP2A, XDH |
5.36427 |
[BP] GO:0043408 |
regulation of MAPK cascade
|
ADORA1, ADRA2A, ADRA2C, ALOX15, DRD2, DRD4, DUSP3, EGFR, FLT3, IGF1R, INSR, KDR, SRC, TEK, XDH |
5.36427 |
[BP] GO:0010817 |
regulation of hormone levels
|
ACHE, ADORA1, ADRA2A, ADRA2C, AKR1B1, CYP19A1, CYP1A1, CYP1B1, DRD2, EGFR, HCAR2, HSD17B1, HSD17B2 |
5.36427 |
[BP] GO:0001505 |
regulation of neurotransmitter levels
|
ACHE, CYP1B1, DRD2, DRD3, DRD4, EGFR, INSR, SLC6A2, SLC6A3, SMAD3 |
5.35919 |
[BP] GO:0043410 |
positive regulation of MAPK cascade
|
ADORA1, ADRA2A, ADRA2C, ALOX15, DRD2, DRD4, EGFR, FLT3, INSR, KDR, SRC, TEK, XDH |
5.35586 |
[BP] GO:0018212 |
peptidyl-tyrosine modification
|
AXL, EGFR, FLT3, IGF1R, INSR, KDR, MET, SRC, TEK |
5.35112 |
[BP] GO:0042493 |
response to drug
|
AKR1B1, APEX1, AXL, CA9, CYP1A1, CYP1B1, DRD2, DRD3, DRD4, EGFR, FABP3, KDR, SLC6A2, SLC6A3, SRC |
5.25069 |
[BP] GO:0009719 |
response to endogenous stimulus
|
ADRA2A, AKR1B1, APEX1, CA2, CA9, CSNK2A1, CYP1A2, EGFR, FABP3, FLT3, IGF1R, INSR, MMP2, PPARA, SMAD3, SRC, TEK |
5.21167 |
[BP] GO:0043069 |
negative regulation of programmed cell death
|
ADORA1, AKR1B1, AURKB, AXL, CSNK2A1, EGFR, GLO1, HSPA1A, IGF1R, KDR, MET, MMP9, PIM1, SMAD3, SRC, TEK |
5.15239 |
[BP] GO:0019220 |
regulation of phosphate metabolic process
|
ADORA1, ADRA2A, ADRA2C, ALOX15, DRD2, DRD3, DRD4, DUSP3, EGFR, FABP3, FABP4, FLT3, IGF1R, INSR, KDR, MMP9, NUAK1, PPARA, SMAD3, SRC, TEK, XDH |
5.05708 |
[BP] GO:0019216 |
regulation of lipid metabolic process
|
ADORA1, ADRA2A, CYP1A1, DRD3, EPHX2, FABP3, FLT3, HCAR2, PPARA, SRC, TEK |
5.01008 |
[BP] GO:0051174 |
regulation of phosphorus metabolic process
|
ADORA1, ADRA2A, ADRA2C, ALOX15, DRD2, DRD3, DRD4, DUSP3, EGFR, FABP3, FABP4, FLT3, IGF1R, INSR, KDR, MMP9, NUAK1, PPARA, SMAD3, SRC, TEK, XDH |
5.01008 |
[BP] GO:0009725 |
response to hormone
|
ADRA2A, AKR1B1, APEX1, CA2, CA9, CSNK2A1, CYP1A2, EGFR, FABP3, FLT3, INSR, PPARA, SRC, TEK |
5.00993 |
[BP] GO:0048583 |
regulation of response to stimulus
|
ADORA1, ADRA2A, ADRA2C, AKR1B1, ALOX15, AURKB, AXL, CSNK2A1, CYP19A1, CYP1B1, DRD2, DRD3, DRD4, DUSP3, EGFR, F10, FABP4, FLT3, GPR35, HSPA1A, IGF1R, INSR, KDR, MET, MMP12, MMP2, MMP9, NUAK1, PPARA, SLC6A3, SMAD3, SRC, TEK, XDH |
4.94982 |
[BP] GO:0032787 |
None
|
ALOX15, ALOX5, CBR1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, EPHX2, FABP3, GLO1, PPARA |
4.77332 |
[BP] GO:0009966 |
regulation of signal transduction
|
ADORA1, ADRA2A, ADRA2C, AKR1B1, ALOX15, AURKB, AXL, CSNK2A1, CYP1B1, DRD2, DRD3, DRD4, DUSP3, EGFR, F10, FLT3, GPR35, HSPA1A, IGF1R, INSR, KDR, MET, MMP12, MMP9, NUAK1, SMAD3, SRC, TEK, XDH |
4.76331 |
[BP] GO:0034614 |
cellular response to reactive oxygen species
|
AKR1B1, APEX1, AXL, CYP1B1, EGFR, MMP9, SRC |
4.70501 |
[BP] GO:0048878 |
chemical homeostasis
|
ADRA2A, AKR1B1, CA12, CA2, CA7, DRD2, DRD3, DRD4, EGFR, EPHX2, FABP3, FABP4, GPR35, INSR, MET, SMAD3 |
4.70501 |
[BP] GO:0009056 |
catabolic process
|
ACHE, ADORA1, AURKB, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A6, EPHX1, EPHX2, FABP3, FABP4, FUT7, HSPA1A, MMP1, MMP12, MMP2, MMP9, SLC6A3, SRC, XDH |
4.69647 |
[BP] GO:0051049 |
regulation of transport
|
ACHE, ADORA1, ADRA2A, ADRA2C, ALOX15, AXL, CA2, CA7, CYP19A1, DRD2, DRD3, DRD4, EGFR, GPR35, HCAR2, HSPA1A, INSR, MMP12, MMP9, PPARA, SMAD3, SRC |
4.60395 |
[BP] GO:0043066 |
negative regulation of apoptotic process
|
ADORA1, AKR1B1, AURKB, AXL, CSNK2A1, EGFR, GLO1, HSPA1A, IGF1R, KDR, MMP9, PIM1, SMAD3, SRC, TEK |
4.48256 |
[BP] GO:0009611 |
response to wounding
|
ACHE, ADORA3, ALOX15, CYP1A1, DRD2, EGFR, PPARA, SMAD3 |
4.42119 |
[BP] GO:0032413 |
None
|
ADRA2A, DRD2, DRD3, DRD4, GPR35, MMP9 |
4.32865 |
[BP] GO:0008284 |
positive regulation of cell proliferation
|
ADRA2A, AKR1B1, CSNK2A1, DRD2, DRD3, EGFR, FLT3, IGF1R, INSR, KDR, MMP12, MMP2, MMP9, PIM1, TEK |
4.30334 |
[BP] GO:0051952 |
None
|
ADORA1, ADRA2A, ADRA2C, DRD2, DRD3, DRD4 |
4.30286 |
[BP] GO:0044092 |
negative regulation of molecular function
|
ADORA3, ADRA2A, AURKB, CSNK2A1, CYP1B1, DRD2, DRD3, DRD4, DUSP3, FABP4, GPR35, IGF1R, MET, MMP9, PIM1, PPARA, SRC |
4.25549 |
[BP] GO:0055114 |
oxidation-reduction process
|
AKR1B1, ALOX15, ALOX5, APEX1, CBR1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, HSD17B1, HSD17B2, TYR, XDH |
4.25549 |
[BP] GO:0018958 |
None
|
AKR1B1, DRD2, DRD3, DRD4, SLC6A3, TYR |
4.25549 |
[BP] GO:0030335 |
positive regulation of cell migration
|
ADRA2A, EGFR, F10, IGF1R, INSR, KDR, MET, MMP9, SMAD3, SRC, TEK |
4.25155 |
[BP] GO:0048519 |
negative regulation of biological process
|
ACHE, ADORA1, ADORA3, ADRA2A, ADRA2C, AKR1B1, ALOX15, APEX1, AURKB, AXL, CSNK2A1, CYP19A1, CYP1B1, DRD2, DRD3, DRD4, DUSP3, EGFR, FABP3, FABP4, GLO1, GPR35, HCAR2, HSPA1A, IGF1R, KDR, MET, MMP12, MMP9, PIM1, PPARA, SLC6A3, SMAD3, SRC, TEK, TOP2A, XDH |
4.22915 |
[BP] GO:0034599 |
cellular response to oxidative stress
|
AKR1B1, APEX1, AXL, CYP1B1, EGFR, HSPA1A, MMP9, SRC |
4.20431 |
[BP] GO:0070887 |
cellular response to chemical stimulus
|
ADRA2A, AKR1B1, ALOX15, APEX1, AXL, CYP1A1, CYP1A2, CYP1B1, EGFR, FABP4, FLT3, HSPA1A, IGF1R, INSR, KDR, MMP2, MMP9, SMAD3, SRC |
4.18675 |
[BP] GO:0048585 |
negative regulation of response to stimulus
|
ADORA1, ADRA2A, ALOX15, CYP19A1, DRD2, DRD3, DUSP3, EGFR, HSPA1A, IGF1R, MET, MMP12, MMP9, PPARA, SLC6A3, SMAD3, SRC, TEK, XDH |
4.18675 |
[BP] GO:0048513 |
animal organ development
|
ACHE, AXL, CA2, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, EGFR, FLT3, HSD17B2, INSR, KDR, PPARA, SMAD3, SRC, TEK, TYR |
4.18675 |
[BP] GO:0002791 |
None
|
ACHE, ADORA1, ADRA2A, ADRA2C, DRD2, DRD3, DRD4, EGFR, HCAR2, MMP12, SRC |
4.18176 |
[BP] GO:0006584 |
None
|
AKR1B1, DRD2, DRD3, DRD4, SLC6A3 |
4.18176 |
[BP] GO:0009712 |
None
|
AKR1B1, DRD2, DRD3, DRD4, SLC6A3 |
4.18176 |
[BP] GO:0032502 |
developmental process
|
ACHE, ADORA1, AKR1B1, ALOX15, APEX1, AURKB, AXL, CA2, CA9, CBR1, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, DRD2, DUSP3, EGFR, FABP4, FLT3, FUT7, GLO1, HSD17B2, INSR, KDR, MET, MMP2, MMP9, PIM1, PPARA, SLC6A3, SMAD3, SRC, TEK, TOP2A, TYR |
4.15965 |
[BP] GO:0032410 |
None
|
ADRA2A, DRD2, DRD3, DRD4, GPR35, MMP9 |
4.14568 |
[BP] GO:1904063 |
None
|
ADRA2A, DRD2, DRD3, DRD4, GPR35, MMP9 |
4.14568 |
[BP] GO:2000147 |
positive regulation of cell motility
|
ADRA2A, EGFR, F10, IGF1R, INSR, KDR, MET, MMP9, SMAD3, SRC, TEK |
4.14431 |
[BP] GO:0048511 |
rhythmic process
|
AXL, CSNK2A1, DRD2, DRD3, DRD4, EGFR, PPARA, SRC, TOP2A |
4.04681 |
[BP] GO:0043271 |
negative regulation of ion transport
|
ADORA1, ADRA2A, DRD2, DRD3, DRD4, GPR35, MMP9 |
4.04545 |
[BP] GO:0051272 |
positive regulation of cellular component movement
|
ADRA2A, EGFR, F10, IGF1R, INSR, KDR, MET, MMP9, SMAD3, SRC, TEK |
4.04545 |
[BP] GO:0051240 |
positive regulation of multicellular organismal process
|
ADRA2A, ADRA2C, AXL, CA2, CYP1B1, DRD2, DRD3, EGFR, HCAR2, HSPA1A, KDR, MET, MMP12, MMP9, PIM1, SLC6A3, SMAD3, SRC, TEK |
4.02895 |
[BP] GO:0038083 |
peptidyl-tyrosine autophosphorylation
|
EGFR, IGF1R, INSR, KDR, SRC |
4.02708 |
[BP] GO:0032844 |
regulation of homeostatic process
|
ADORA1, ADRA2A, AURKB, CA2, CA7, DRD2, DRD3, EGFR, HCAR2, KDR, SRC |
4.01952 |
[BP] GO:0051050 |
positive regulation of transport
|
ACHE, ADORA1, ADRA2A, AXL, CA2, CYP19A1, DRD2, DRD3, DRD4, EGFR, HCAR2, INSR, MMP12, SMAD3, SRC |
3.95268 |
[BP] GO:0010562 |
positive regulation of phosphorus metabolic process
|
ADORA1, ADRA2A, ADRA2C, ALOX15, DRD2, DRD4, EGFR, FABP3, FLT3, INSR, KDR, MMP9, SMAD3, SRC, TEK, XDH |
3.95268 |
[BP] GO:0045937 |
positive regulation of phosphate metabolic process
|
ADORA1, ADRA2A, ADRA2C, ALOX15, DRD2, DRD4, EGFR, FABP3, FLT3, INSR, KDR, MMP9, SMAD3, SRC, TEK, XDH |
3.95268 |
[BP] GO:0040017 |
positive regulation of locomotion
|
ADRA2A, EGFR, F10, IGF1R, INSR, KDR, MET, MMP9, SMAD3, SRC, TEK |
3.92402 |
[BP] GO:0034766 |
None
|
ADRA2A, DRD2, DRD3, DRD4, GPR35, MMP9 |
3.88297 |
[BP] GO:0051897 |
positive regulation of protein kinase B signaling
|
AXL, EGFR, F10, INSR, MET, SRC, TEK |
3.8617 |
[BP] GO:0007169 |
transmembrane receptor protein tyrosine kinase signaling pathway
|
AXL, EGFR, FLT3, IGF1R, INSR, KDR, MET, MMP2, MMP9, SRC, TEK |
3.83872 |
[BP] GO:0003018 |
None
|
ADORA1, ADRA2A, ADRA2C, EGFR, EPHX2, SRC, TEK |
3.81673 |
[BP] GO:0019752 |
carboxylic acid metabolic process
|
ALOX15, ALOX5, CBR1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, EPHX2, FABP3, GLO1, PIM1, PPARA, TYR |
3.81673 |
[BP] GO:0010648 |
negative regulation of cell communication
|
ACHE, ADORA1, ADRA2A, ADRA2C, DRD2, DRD3, DUSP3, EGFR, GPR35, HSPA1A, IGF1R, MET, MMP12, MMP9, SMAD3, SRC, XDH |
3.81383 |
[BP] GO:0042752 |
None
|
ADORA1, DRD2, DRD3, DRD4, PPARA, TOP2A |
3.80299 |
[BP] GO:0023057 |
negative regulation of signaling
|
ACHE, ADORA1, ADRA2A, ADRA2C, DRD2, DRD3, DUSP3, EGFR, GPR35, HSPA1A, IGF1R, MET, MMP12, MMP9, SMAD3, SRC, XDH |
3.80299 |
[BP] GO:0051953 |
None
|
ADORA1, ADRA2A, ADRA2C, DRD2 |
3.80299 |
[BP] GO:0051701 |
interaction with host
|
AXL, EGFR, HSPA1A, INSR, MET, SMAD3, SRC |
3.78173 |
[BP] GO:0009628 |
response to abiotic stimulus
|
ADORA1, AKR1B1, AURKB, CA2, CYP1A1, DRD2, DRD3, EGFR, HSPA1A, MMP2, PPARA, SMAD3, SRC, TEK, TYR |
3.78173 |
[BP] GO:0009987 |
cellular process
|
ACHE, ADORA1, ADORA3, ADRA2A, ADRA2C, AKR1B1, ALOX15, ALOX5, APEX1, AURKB, AXL, CA1, CA12, CA2, CA4, CA5A, CA5B, CA6, CA7, CA9, CBR1, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, DRD2, DRD3, DRD4, DUSP3, EGFR, EPHX1, EPHX2, F10, FABP3, FABP4, FLT3, FUT7, GLO1, GPR35, HCAR2, HSD17B1, HSD17B2, HSPA1A, IGF1R, INSR, KDR, MET, MMP1, MMP12, MMP2, MMP9, NUAK1, PIM1, PPARA, SLC6A2, SLC6A3, SMAD3, SRC, TEK, TOP2A, TYR, XDH |
3.78173 |
[BP] GO:0034763 |
None
|
ADRA2A, DRD2, DRD3, DRD4, GPR35, MMP9 |
3.76721 |
[BP] GO:0006811 |
None
|
CA1, CA12, CA14, CA2, CA4, CA5A, CA5B, CA6, CA7, CA9, DRD2, DRD3, DRD4, FABP3, PPARA, SLC6A2, SLC6A3 |
3.74963 |
[BP] GO:0006796 |
phosphate-containing compound metabolic process
|
ACHE, ALOX15, APEX1, AURKB, AXL, CSNK2A1, DRD2, DUSP3, EGFR, EPHX2, FLT3, HSPA1A, IGF1R, INSR, KDR, MET, NUAK1, PIM1, SRC, TEK, XDH |
3.74824 |
[BP] GO:0048523 |
negative regulation of cellular process
|
ACHE, ADORA1, ADORA3, ADRA2A, ADRA2C, AKR1B1, APEX1, AURKB, AXL, CSNK2A1, CYP19A1, CYP1B1, DRD2, DRD3, DRD4, DUSP3, EGFR, FABP3, FABP4, GLO1, GPR35, HSPA1A, IGF1R, KDR, MET, MMP12, MMP9, PIM1, PPARA, SMAD3, SRC, TEK, TOP2A, XDH |
3.74824 |
[BP] GO:0008210 |
estrogen metabolic process
|
CYP19A1, CYP1B1, HSD17B1, HSD17B2 |
3.74824 |
[BP] GO:0080134 |
regulation of response to stress
|
ADORA1, ADRA2A, CYP19A1, DRD2, DUSP3, EGFR, FABP4, HSPA1A, IGF1R, MET, MMP12, MMP2, NUAK1, PPARA, SMAD3, SRC, TEK, XDH |
3.74214 |
[BP] GO:0009698 |
phenylpropanoid metabolic process
|
CYP1A1, CYP2A13, CYP2A6 |
3.73771 |
[BP] GO:0009804 |
coumarin metabolic process
|
CYP1A1, CYP2A13, CYP2A6 |
3.73771 |
[BP] GO:0010038 |
response to metal ion
|
ALOX15, CA2, CYP1A1, CYP1A2, DRD2, EGFR, FABP4, MMP9, SLC6A3 |
3.73771 |
[BP] GO:1901615 |
organic hydroxy compound metabolic process
|
AKR1B1, ALOX15, CYP19A1, CYP1A1, CYP1B1, DRD2, DRD3, DRD4, SLC6A3, TYR |
3.73771 |
[BP] GO:0050708 |
None
|
ACHE, ADRA2A, ADRA2C, DRD2, DRD3, DRD4, EGFR, HCAR2, MMP12, SRC |
3.64724 |
[BP] GO:0034754 |
cellular hormone metabolic process
|
AKR1B1, CYP19A1, CYP1A1, CYP1B1, HSD17B1, HSD17B2 |
3.60339 |
[BP] GO:0006950 |
response to stress
|
ACHE, ADORA1, ADORA3, AKR1B1, ALOX15, APEX1, AXL, CA2, CA9, CYP1A1, CYP1A2, CYP1B1, DRD2, DRD4, EGFR, EPHX2, HSPA1A, MMP2, MMP9, NUAK1, PPARA, SLC6A2, SMAD3, SRC, TEK, TOP2A |
3.60339 |
[BP] GO:0031348 |
negative regulation of defense response
|
ADORA1, CYP19A1, DRD2, MMP12, PPARA, SMAD3, TEK |
3.59485 |
[BP] GO:0042325 |
regulation of phosphorylation
|
ADORA1, ADRA2A, ADRA2C, ALOX15, DRD2, DRD4, DUSP3, EGFR, FABP4, FLT3, IGF1R, INSR, KDR, MMP9, PPARA, SRC, TEK, XDH |
3.5905 |
[BP] GO:0008202 |
steroid metabolic process
|
AKR1B1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A6, HSD17B1, HSD17B2 |
3.59048 |
[BP] GO:0032101 |
regulation of response to external stimulus
|
ADORA1, CYP19A1, DRD2, DRD3, EGFR, FABP4, KDR, MET, MMP12, PPARA, SLC6A3, SMAD3, TEK |
3.57075 |
[BP] GO:0051940 |
None
|
DRD2, DRD3, DRD4 |
3.57075 |
[BP] GO:0051584 |
None
|
DRD2, DRD3, DRD4 |
3.57075 |
[BP] GO:0000302 |
response to reactive oxygen species
|
AKR1B1, APEX1, AXL, CYP1B1, EGFR, MMP9, SRC |
3.57054 |
[BP] GO:0043405 |
regulation of MAP kinase activity
|
ADORA1, ADRA2A, DRD4, DUSP3, EGFR, FLT3, IGF1R, INSR, SRC |
3.55087 |
[BP] GO:0042417 |
None
|
DRD2, DRD3, DRD4, SLC6A3 |
3.52371 |
[BP] GO:0071310 |
cellular response to organic substance
|
ADRA2A, AKR1B1, ALOX15, APEX1, AXL, CYP1A1, CYP1B1, EGFR, FABP4, FLT3, IGF1R, INSR, KDR, MMP2, SMAD3, SRC |
3.51355 |
[BP] GO:0006805 |
xenobiotic metabolic process
|
CYP1A1, CYP1A2, CYP1B1, CYP2A13, EPHX1, EPHX2 |
3.50602 |
[BP] GO:0006793 |
phosphorus metabolic process
|
ACHE, ALOX15, APEX1, AURKB, AXL, CSNK2A1, DRD2, DUSP3, EGFR, EPHX2, FLT3, HSPA1A, IGF1R, INSR, KDR, MET, NUAK1, PIM1, SRC, TEK, XDH |
3.49413 |
[BP] GO:0007167 |
enzyme linked receptor protein signaling pathway
|
AXL, EGFR, FLT3, IGF1R, INSR, KDR, MET, MMP2, MMP9, SMAD3, SRC, TEK |
3.49307 |
[BP] GO:0001932 |
regulation of protein phosphorylation
|
ADORA1, ADRA2A, ADRA2C, ALOX15, DRD2, DRD4, DUSP3, EGFR, FABP4, FLT3, IGF1R, INSR, KDR, MMP9, SRC, TEK, XDH |
3.48566 |
[BP] GO:0001666 |
response to hypoxia
|
ADORA1, CYP1A1, DRD2, MMP2, PPARA, SMAD3, SRC, TEK |
3.47773 |
[BP] GO:0097164 |
None
|
ACHE, AKR1B1, CSNK2A1, DRD2, DRD3, DRD4, SLC6A3 |
3.46537 |
[BP] GO:0051716 |
cellular response to stimulus
|
ADRA2A, AKR1B1, ALOX15, APEX1, AURKB, AXL, CA2, CA9, CYP1A1, CYP1A2, CYP1B1, EGFR, FABP4, FLT3, HSPA1A, IGF1R, INSR, KDR, MMP2, MMP9, NUAK1, SMAD3, SRC, TOP2A |
3.45554 |
[BP] GO:1903530 |
regulation of secretion by cell
|
ACHE, ADORA1, ADRA2A, ADRA2C, CYP19A1, DRD2, DRD3, DRD4, EGFR, HCAR2, MMP12, SRC |
3.45554 |
[BP] GO:0001934 |
positive regulation of protein phosphorylation
|
ADORA1, ADRA2A, ADRA2C, ALOX15, DRD2, DRD4, EGFR, FLT3, INSR, KDR, MMP9, SRC, TEK, XDH |
3.44346 |
[BP] GO:0090087 |
None
|
ACHE, ADORA1, ADRA2A, ADRA2C, CA2, DRD2, DRD3, DRD4, EGFR, HCAR2, MMP12, SMAD3, SRC |
3.44234 |
[BP] GO:0043436 |
oxoacid metabolic process
|
ALOX15, ALOX5, CBR1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, EPHX2, FABP3, GLO1, PIM1, PPARA, TYR |
3.44194 |
[BP] GO:0042445 |
hormone metabolic process
|
ACHE, AKR1B1, CYP19A1, CYP1A1, CYP1B1, HSD17B1, HSD17B2 |
3.43928 |
[BP] GO:0015908 |
None
|
DRD2, DRD3, DRD4, FABP3, PPARA |
3.43037 |
[BP] GO:0036293 |
response to decreased oxygen levels
|
ADORA1, CYP1A1, DRD2, MMP2, PPARA, SMAD3, SRC, TEK |
3.41321 |
[BP] GO:0050806 |
positive regulation of synaptic transmission
|
ADORA1, CA2, CA7, DRD2, DRD4, EGFR |
3.40216 |
[BP] GO:0045744 |
None
|
ADRA2A, DRD2, DRD3, MET |
3.39437 |
[BP] GO:0006082 |
organic acid metabolic process
|
ALOX15, ALOX5, CBR1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, EPHX2, FABP3, GLO1, PIM1, PPARA, TYR |
3.37074 |
[BP] GO:0050790 |
regulation of catalytic activity
|
ADORA1, ADORA3, ADRA2A, ADRA2C, AURKB, CSNK2A1, DRD2, DRD3, DRD4, DUSP3, EGFR, FABP4, FLT3, HSPA1A, IGF1R, INSR, MMP9, NUAK1, SMAD3, SRC, TEK, XDH |
3.34622 |
[BP] GO:0007194 |
None
|
ADRA2A, DRD2, DRD3, DRD4 |
3.34622 |
[BP] GO:0032228 |
regulation of synaptic transmission, GABAergic
|
ADORA1, CA2, CA7, DRD2 |
3.34622 |
[BP] GO:1900543 |
None
|
ADRA2A, DRD2, DRD3, DRD4, PPARA |
3.32725 |
[BP] GO:0007195 |
None
|
DRD2, DRD3, DRD4 |
3.31898 |
[BP] GO:0097267 |
omega-hydroxylase P450 pathway
|
CYP1A1, CYP1A2, CYP1B1 |
3.31898 |
[BP] GO:0045787 |
positive regulation of cell cycle
|
APEX1, AURKB, CYP1A1, DRD2, DRD3, DUSP3, EGFR, INSR, SRC |
3.31566 |
[BP] GO:0031399 |
regulation of protein modification process
|
ADORA1, ADRA2A, ADRA2C, ALOX15, DRD2, DRD4, DUSP3, EGFR, FABP4, FLT3, HSPA1A, IGF1R, INSR, KDR, MMP9, NUAK1, SRC, TEK, XDH |
3.31288 |
[BP] GO:0045980 |
None
|
ADRA2A, DRD2, DRD3, DRD4, PPARA |
3.30985 |
[BP] GO:0032102 |
negative regulation of response to external stimulus
|
ADORA1, CYP19A1, DRD2, DRD3, PPARA, SLC6A3, SMAD3, TEK |
3.30403 |
[BP] GO:0043549 |
regulation of kinase activity
|
ADORA1, ADRA2A, ADRA2C, DRD2, DRD4, DUSP3, EGFR, FABP4, FLT3, IGF1R, INSR, SRC, TEK |
3.28414 |
[BP] GO:0042327 |
positive regulation of phosphorylation
|
ADORA1, ADRA2A, ADRA2C, ALOX15, DRD2, DRD4, EGFR, FLT3, INSR, KDR, MMP9, SRC, TEK, XDH |
3.27766 |
[BP] GO:0033993 |
response to lipid
|
AXL, CA2, CA9, CSNK2A1, CYP1A1, CYP1A2, EGFR, FABP3, FLT3, HSD17B2, SRC, TYR |
3.27132 |
[BP] GO:0032148 |
None
|
ADRA2A, ADRA2C, INSR, SRC |
3.26923 |
[BP] GO:0031280 |
None
|
ADRA2A, DRD2, DRD3, DRD4 |
3.26923 |
[BP] GO:0071704 |
organic substance metabolic process
|
ACHE, ADORA1, AKR1B1, ALOX15, ALOX5, APEX1, AURKB, AXL, CBR1, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, DRD2, DRD3, DRD4, DUSP3, EGFR, EPHX1, EPHX2, F10, FABP3, FABP4, FLT3, FUT7, GLO1, HSD17B1, HSD17B2, HSPA1A, IGF1R, INSR, KDR, MET, MMP1, MMP12, MMP2, MMP9, NUAK1, PIM1, PPARA, SLC6A3, SMAD3, SRC, TEK, TOP2A, TYR, XDH |
3.25825 |
[BP] GO:0051047 |
None
|
ACHE, ADORA1, CYP19A1, DRD2, DRD3, EGFR, HCAR2, MMP12, SRC |
3.2417 |
[BP] GO:0007193 |
None
|
ADORA1, ADRA2A, DRD2, DRD3, DRD4 |
3.21806 |
[BP] GO:0034776 |
None
|
DRD2, DRD3, DRD4 |
3.2165 |
[BP] GO:0003013 |
None
|
ADORA1, ADRA2A, ADRA2C, EGFR, EPHX2, SRC, TEK |
3.21245 |
[BP] GO:0051046 |
None
|
ACHE, ADORA1, ADRA2A, ADRA2C, CYP19A1, DRD2, DRD3, DRD4, EGFR, HCAR2, MMP12, SRC |
3.21245 |
[BP] GO:0070482 |
response to oxygen levels
|
ADORA1, CYP1A1, DRD2, MMP2, PPARA, SMAD3, SRC, TEK |
3.19996 |
[BP] GO:0051350 |
None
|
ADRA2A, DRD2, DRD3, DRD4 |
3.18533 |
[BP] GO:2000021 |
regulation of ion homeostasis
|
ADORA1, CA2, CA7, DRD2, DRD3, KDR, SRC |
3.1793 |
[BP] GO:0051338 |
regulation of transferase activity
|
ADORA1, ADRA2A, ADRA2C, AURKB, DRD2, DRD4, DUSP3, EGFR, FABP4, FLT3, IGF1R, INSR, SRC, TEK |
3.1793 |
[BP] GO:0010638 |
positive regulation of organelle organization
|
ALOX15, AURKB, DRD3, HSPA1A, INSR, KDR, MET, MMP9, SMAD3, SRC, TEK |
3.1793 |
[BP] GO:0018193 |
peptidyl-amino acid modification
|
AURKB, AXL, CSNK2A1, EGFR, F10, FLT3, IGF1R, INSR, KDR, MET, SRC, TEK, TOP2A |
3.16225 |
[BP] GO:0051130 |
positive regulation of cellular component organization
|
ALOX15, AURKB, AXL, DRD2, DRD3, HSPA1A, IGF1R, INSR, KDR, MET, MMP1, MMP9, SMAD3, SRC, TEK |
3.14819 |
[BP] GO:0045742 |
None
|
ADORA1, ADRA2A, ADRA2C, MMP9 |
3.14819 |
[BP] GO:0045741 |
None
|
ADORA1, ADRA2A, ADRA2C |
3.11745 |
[BP] GO:0050804 |
modulation of chemical synaptic transmission
|
ACHE, ADORA1, CA2, CA7, DRD2, DRD3, DRD4, EGFR |
3.11547 |
[BP] GO:0099177 |
regulation of trans-synaptic signaling
|
ACHE, ADORA1, CA2, CA7, DRD2, DRD3, DRD4, EGFR |
3.11547 |
[BP] GO:0065009 |
regulation of molecular function
|
ADORA1, ADORA3, ADRA2A, ADRA2C, AURKB, CSNK2A1, CYP1B1, DRD2, DRD3, DRD4, DUSP3, EGFR, FABP4, FLT3, GPR35, HSPA1A, IGF1R, INSR, MET, MMP9, NUAK1, PIM1, PPARA, SMAD3, SRC, TEK, XDH |
3.07232 |
[BP] GO:1901186 |
None
|
ADORA1, ADRA2A, ADRA2C, MMP9 |
3.0699 |
[BP] GO:1901020 |
None
|
ADRA2A, DRD2, DRD4, GPR35 |
3.0699 |
[BP] GO:0044057 |
None
|
ADORA1, ADORA3, ADRA2A, ADRA2C, DRD2, DRD3, EGFR, GPR35, HCAR2, SMAD3 |
3.05039 |
[BP] GO:1901564 |
organonitrogen compound metabolic process
|
ACHE, AKR1B1, AURKB, AXL, CSNK2A1, CYP1A1, CYP1A2, DRD2, DRD3, DRD4, DUSP3, EGFR, F10, FLT3, FUT7, GLO1, HSPA1A, IGF1R, INSR, KDR, MET, MMP1, MMP12, MMP2, MMP9, NUAK1, PIM1, PPARA, SLC6A3, SMAD3, SRC, TEK, TOP2A, TYR, XDH |
3.05039 |
[BP] GO:0006703 |
estrogen biosynthetic process
|
CYP19A1, HSD17B1, HSD17B2 |
3.02452 |
[BP] GO:0060134 |
None
|
DRD2, DRD3, SLC6A3 |
3.02452 |
[BP] GO:0033604 |
None
|
ADRA2A, ADRA2C, DRD2 |
3.02452 |
[BP] GO:0042058 |
None
|
ADORA1, ADRA2A, ADRA2C, EGFR, MMP9 |
3.00266 |
[BP] GO:0032147 |
activation of protein kinase activity
|
ADORA1, ADRA2A, ADRA2C, DRD2, DRD4, EGFR, INSR, SRC |
3.0018 |
[BP] GO:0071248 |
cellular response to metal ion
|
ALOX15, CYP1A1, CYP1A2, EGFR, FABP4, MMP9 |
3.00062 |
[BP] GO:0008217 |
None
|
ADORA1, DRD2, DRD3, EPHX2, PPARA, SMAD3 |
2.9879 |
[BP] GO:0032846 |
positive regulation of homeostatic process
|
AURKB, CA2, CA7, DRD2, DRD3, EGFR, HCAR2 |
2.9879 |
[BP] GO:0010604 |
positive regulation of macromolecule metabolic process
|
ADORA1, ADRA2A, ADRA2C, ALOX15, AURKB, CSNK2A1, DRD2, DRD3, DRD4, EGFR, EPHX2, FLT3, HSPA1A, IGF1R, INSR, KDR, MET, MMP12, MMP9, PPARA, SMAD3, SRC, TEK, TOP2A, XDH |
2.97712 |
[BP] GO:0045776 |
None
|
ADORA1, DRD2, DRD3, PPARA |
2.96416 |
[BP] GO:0051239 |
regulation of multicellular organismal process
|
ADORA1, ADORA3, ADRA2A, ADRA2C, AXL, CA2, CYP1B1, DRD2, DRD3, EGFR, GPR35, HCAR2, HSPA1A, INSR, KDR, MET, MMP12, MMP9, PIM1, SLC6A3, SMAD3, SRC, TEK, XDH |
2.96054 |
[BP] GO:0031347 |
regulation of defense response
|
ADORA1, CYP19A1, DRD2, EGFR, FABP4, HSPA1A, MMP12, MMP2, PPARA, SMAD3, SRC, TEK |
2.96054 |
[BP] GO:0045859 |
regulation of protein kinase activity
|
ADORA1, ADRA2A, ADRA2C, DRD2, DRD4, DUSP3, EGFR, FABP4, FLT3, IGF1R, INSR, SRC |
2.95125 |
[BP] GO:0007346 |
regulation of mitotic cell cycle
|
APEX1, AURKB, CYP1A1, DRD3, DUSP3, EGFR, HSPA1A, INSR, PIM1, SMAD3, TOP2A |
2.94991 |
[BP] GO:0051580 |
None
|
DRD2, DRD3, DRD4 |
2.9433 |
[BP] GO:1903170 |
None
|
ADRA2A, DRD2, DRD4, GPR35 |
2.93472 |
[BP] GO:1903727 |
positive regulation of phospholipid metabolic process
|
FABP3, FLT3, SRC, TEK |
2.93472 |
[BP] GO:0006468 |
protein phosphorylation
|
AURKB, AXL, CSNK2A1, EGFR, FLT3, IGF1R, INSR, KDR, MET, NUAK1, PIM1, SRC, TEK |
2.91761 |
[BP] GO:0048856 |
anatomical structure development
|
ACHE, ADORA1, AKR1B1, ALOX15, AXL, CA2, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, DRD2, DUSP3, EGFR, FLT3, HSD17B2, INSR, KDR, MMP9, PIM1, PPARA, SLC6A3, SMAD3, SRC, TEK, TYR |
2.91168 |
[BP] GO:0030818 |
None
|
ADRA2A, DRD2, DRD3, DRD4 |
2.90075 |
[BP] GO:0050801 |
ion homeostasis
|
CA12, CA2, CA7, DRD2, DRD3, DRD4, EGFR, EPHX2, FABP3, GPR35, SMAD3 |
2.90075 |
[BP] GO:0007188 |
None
|
ADORA1, ADRA2A, ADRA2C, DRD2, DRD3, DRD4 |
2.89917 |
[BP] GO:0033674 |
positive regulation of kinase activity
|
ADORA1, ADRA2A, ADRA2C, DRD2, DRD4, EGFR, FLT3, INSR, SRC, TEK |
2.88975 |
[BP] GO:0051234 |
None
|
ACHE, ADORA1, ADRA2A, ALOX15, ALOX5, AXL, CA1, CA12, CA14, CA2, CA4, CA5A, CA5B, CA6, CA7, CA9, DRD2, DRD3, DRD4, EGFR, F10, FABP3, HSPA1A, MMP12, MMP9, PPARA, SLC6A2, SLC6A3, SRC, XDH |
2.87746 |
[BP] GO:0045761 |
None
|
ADRA2A, DRD2, DRD3, DRD4 |
2.86829 |
[BP] GO:0009893 |
positive regulation of metabolic process
|
ADORA1, ADRA2A, ADRA2C, ALOX15, AURKB, CSNK2A1, DRD2, DRD3, DRD4, EGFR, EPHX2, FABP3, FLT3, HSPA1A, IGF1R, INSR, KDR, MET, MMP12, MMP9, PPARA, SMAD3, SRC, TEK, TOP2A, XDH |
2.83926 |
[BP] GO:0030803 |
None
|
ADRA2A, DRD2, DRD3, DRD4 |
2.83313 |
[BP] GO:0051347 |
positive regulation of transferase activity
|
ADORA1, ADRA2A, ADRA2C, AURKB, DRD2, DRD4, EGFR, FLT3, INSR, SRC, TEK |
2.81703 |
[BP] GO:0051173 |
positive regulation of nitrogen compound metabolic process
|
ADORA1, ADRA2A, ADRA2C, ALOX15, AURKB, CSNK2A1, DRD2, DRD3, DRD4, EGFR, FLT3, HSPA1A, IGF1R, INSR, KDR, MET, MMP12, MMP9, PPARA, SMAD3, SRC, TEK, TOP2A, XDH |
2.80973 |
[BP] GO:0050433 |
None
|
ADRA2A, ADRA2C, DRD2, DRD3 |
2.80041 |
[BP] GO:0032225 |
None
|
DRD2, DRD3, DRD4 |
2.78605 |
[BP] GO:0006979 |
response to oxidative stress
|
AKR1B1, APEX1, AXL, CYP1B1, EGFR, HSPA1A, MMP9, SRC |
2.77355 |
[BP] GO:0030815 |
None
|
ADRA2A, DRD2, DRD3, DRD4 |
2.77005 |
[BP] GO:1901184 |
None
|
ADORA1, ADRA2A, ADRA2C, EGFR, MMP9 |
2.75963 |
[BP] GO:0051247 |
positive regulation of protein metabolic process
|
ADORA1, ADRA2A, ADRA2C, ALOX15, CSNK2A1, DRD2, DRD4, EGFR, FLT3, HSPA1A, INSR, KDR, MMP9, SMAD3, SRC, TEK, XDH |
2.75796 |
[BP] GO:1900372 |
None
|
ADRA2A, DRD2, DRD3, DRD4 |
2.74195 |
[BP] GO:0030809 |
None
|
ADRA2A, DRD2, DRD3, DRD4 |
2.74195 |
[BP] GO:1901652 |
response to peptide
|
AKR1B1, APEX1, FABP3, IGF1R, INSR, PPARA, SRC, TEK |
2.73288 |
[BP] GO:0019222 |
regulation of metabolic process
|
ACHE, ADORA1, ADORA3, ADRA2A, ADRA2C, ALOX15, APEX1, AURKB, CA9, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, DRD2, DRD3, DRD4, DUSP3, EGFR, EPHX2, FABP3, FABP4, FLT3, GLO1, HCAR2, HSPA1A, IGF1R, INSR, KDR, MET, MMP12, MMP9, NUAK1, PIM1, PPARA, SLC6A3, SMAD3, SRC, TEK, TOP2A, XDH |
2.73288 |
[BP] GO:0051828 |
entry into other organism involved in symbiotic interaction
|
AXL, EGFR, HSPA1A, MET, SRC |
2.73288 |
[BP] GO:0051806 |
entry into cell of other organism involved in symbiotic interaction
|
AXL, EGFR, HSPA1A, MET, SRC |
2.73288 |
[BP] GO:0030260 |
entry into host cell
|
AXL, EGFR, HSPA1A, MET, SRC |
2.73288 |
[BP] GO:0044409 |
entry into host
|
AXL, EGFR, HSPA1A, MET, SRC |
2.73288 |
[BP] GO:1901386 |
None
|
DRD2, DRD4, GPR35 |
2.72586 |
[BP] GO:0030800 |
None
|
ADRA2A, DRD2, DRD3, DRD4 |
2.7205 |
[BP] GO:0072593 |
reactive oxygen species metabolic process
|
CYP1A1, CYP1A2, CYP1B1, EGFR, EPHX2 |
2.71712 |
[BP] GO:0002793 |
None
|
ACHE, ADORA1, DRD2, EGFR, HCAR2, MMP12, SRC |
2.71712 |
[BP] GO:0071241 |
cellular response to inorganic substance
|
ALOX15, CYP1A1, CYP1A2, EGFR, FABP4, MMP9 |
2.70437 |
[BP] GO:0080090 |
regulation of primary metabolic process
|
ADORA1, ADORA3, ADRA2A, ADRA2C, ALOX15, APEX1, AURKB, CA9, CSNK2A1, CYP1A1, CYP1B1, DRD2, DRD3, DRD4, DUSP3, EGFR, EPHX2, FABP3, FABP4, FLT3, GLO1, HCAR2, HSPA1A, IGF1R, INSR, KDR, MET, MMP12, MMP9, NUAK1, PIM1, PPARA, SLC6A3, SMAD3, SRC, TEK, TOP2A, XDH |
2.69598 |
[BP] GO:0071702 |
None
|
ADORA1, CA1, CA12, CA14, CA2, CA4, CA5A, CA5B, CA6, CA7, CA9, DRD2, DRD3, DRD4, FABP3, MMP12, PPARA, SLC6A2, SLC6A3 |
2.69517 |
[BP] GO:2001258 |
None
|
DRD2, DRD4, GPR35, MMP9 |
2.695 |
[BP] GO:0006810 |
None
|
ACHE, ADORA1, ADRA2A, ALOX15, ALOX5, AXL, CA1, CA12, CA14, CA2, CA4, CA5A, CA5B, CA6, CA7, CA9, DRD2, DRD3, DRD4, F10, FABP3, HSPA1A, MMP12, MMP9, PPARA, SLC6A2, SLC6A3, SRC, XDH |
2.68109 |
[BP] GO:0050994 |
None
|
ADORA1, ADRA2A, HCAR2, PPARA |
2.66427 |
[BP] GO:0009895 |
negative regulation of catabolic process
|
ADORA1, ADRA2A, EGFR, HCAR2, MET, PPARA, SMAD3 |
2.64311 |
[BP] GO:0046883 |
regulation of hormone secretion
|
ADORA1, ADRA2A, ADRA2C, CYP19A1, DRD2, EGFR, HCAR2 |
2.64311 |
[BP] GO:0015909 |
None
|
DRD2, DRD3, DRD4, FABP3 |
2.63564 |
[BP] GO:0043406 |
positive regulation of MAP kinase activity
|
ADORA1, ADRA2A, DRD4, EGFR, FLT3, INSR, SRC |
2.63548 |
[BP] GO:0051726 |
regulation of cell cycle
|
APEX1, AURKB, CSNK2A1, CYP1A1, DRD2, DRD3, DUSP3, EGFR, HSPA1A, INSR, PIM1, SMAD3, SRC, TOP2A |
2.62815 |
[BP] GO:0042542 |
response to hydrogen peroxide
|
AKR1B1, APEX1, AXL, CYP1B1, SRC |
2.62163 |
[BP] GO:1900673 |
olefin metabolic process
|
CYP1A1, EPHX2 |
2.62163 |
[BP] GO:0051944 |
None
|
DRD2, DRD4 |
2.62163 |
[BP] GO:0060160 |
None
|
DRD2, DRD3 |
2.62163 |
[BP] GO:0032849 |
positive regulation of cellular pH reduction
|
CA2, CA7 |
2.62163 |
[BP] GO:0051586 |
None
|
DRD2, DRD4 |
2.62163 |
[BP] GO:0051893 |
regulation of focal adhesion assembly
|
KDR, SMAD3, SRC, TEK |
2.62163 |
[BP] GO:0090109 |
regulation of cell-substrate junction assembly
|
KDR, SMAD3, SRC, TEK |
2.62163 |
[BP] GO:0045187 |
None
|
ADORA1, DRD2, DRD3 |
2.61146 |
[BP] GO:0007187 |
None
|
ADORA1, ADRA2A, ADRA2C, DRD2, DRD3, DRD4 |
2.5873 |
[BP] GO:1903531 |
None
|
ADORA1, ADRA2A, ADRA2C, DRD2, DRD3, DRD4 |
2.57542 |
[BP] GO:0070372 |
regulation of ERK1 and ERK2 cascade
|
ALOX15, DRD2, DUSP3, EGFR, KDR, SRC, TEK |
2.5565 |
[BP] GO:0048148 |
None
|
DRD2, DRD3, DRD4 |
2.55145 |
[BP] GO:0035813 |
None
|
ADORA1, DRD2, DRD3 |
2.55145 |
[BP] GO:0071880 |
None
|
ADRA2A, ADRA2C, DRD2 |
2.55145 |
[BP] GO:1903391 |
regulation of adherens junction organization
|
KDR, SMAD3, SRC, TEK |
2.54063 |
[BP] GO:0001503 |
ossification
|
ALOX15, EGFR, MMP2, MMP9, TEK |
2.5311 |
[BP] GO:0032270 |
positive regulation of cellular protein metabolic process
|
ADORA1, ADRA2A, ADRA2C, ALOX15, DRD2, DRD4, EGFR, FLT3, HSPA1A, INSR, KDR, MMP9, SMAD3, SRC, TEK, XDH |
2.5311 |
[BP] GO:0051051 |
negative regulation of transport
|
ADORA1, ADRA2A, ADRA2C, DRD2, DRD3, DRD4, GPR35, HSPA1A, MMP9 |
2.51819 |
[BP] GO:0050728 |
negative regulation of inflammatory response
|
ADORA1, CYP19A1, PPARA, SMAD3, TEK |
2.51656 |
[BP] GO:0031325 |
positive regulation of cellular metabolic process
|
ADORA1, ADRA2A, ADRA2C, ALOX15, AURKB, DRD2, DRD3, DRD4, EGFR, FABP3, FLT3, HSPA1A, IGF1R, INSR, KDR, MET, MMP12, MMP9, PPARA, SMAD3, SRC, TEK, TOP2A, XDH |
2.49821 |
[BP] GO:0042749 |
None
|
ADORA1, DRD2, DRD3 |
2.49722 |
[BP] GO:0031401 |
positive regulation of protein modification process
|
ADORA1, ADRA2A, ADRA2C, ALOX15, DRD2, DRD4, EGFR, FLT3, INSR, KDR, MMP9, SRC, TEK, XDH |
2.49722 |
[BP] GO:0035690 |
cellular response to drug
|
AKR1B1, APEX1, AXL, CYP1B1, EGFR, KDR, SRC |
2.49465 |
[BP] GO:0071900 |
regulation of protein serine/threonine kinase activity
|
ADORA1, ADRA2A, DRD4, DUSP3, EGFR, FLT3, IGF1R, INSR, SRC |
2.48033 |
[BP] GO:0050995 |
None
|
ADORA1, ADRA2A, HCAR2 |
2.44383 |
[BP] GO:0070301 |
cellular response to hydrogen peroxide
|
AKR1B1, APEX1, AXL, CYP1B1 |
2.44383 |
[BP] GO:0042446 |
hormone biosynthetic process
|
AKR1B1, CYP19A1, HSD17B1, HSD17B2 |
2.44383 |
[BP] GO:0031279 |
None
|
ADRA2A, DRD2, DRD3, DRD4 |
2.44383 |
[BP] GO:0009894 |
regulation of catabolic process
|
ADORA1, ADRA2A, APEX1, CSNK2A1, EGFR, HCAR2, HSPA1A, INSR, KDR, MET, PPARA, SMAD3 |
2.44383 |
[BP] GO:0097237 |
cellular response to toxic substance
|
AKR1B1, APEX1, AXL, CYP1B1, KDR |
2.44383 |
[BP] GO:0070374 |
positive regulation of ERK1 and ERK2 cascade
|
ALOX15, DRD2, EGFR, KDR, SRC, TEK |
2.43913 |
[BP] GO:0051339 |
None
|
ADRA2A, DRD2, DRD3, DRD4 |
2.41977 |
[BP] GO:0045860 |
positive regulation of protein kinase activity
|
ADORA1, ADRA2A, ADRA2C, DRD2, DRD4, EGFR, FLT3, INSR, SRC |
2.41946 |
[BP] GO:0098771 |
inorganic ion homeostasis
|
CA12, CA2, CA7, DRD2, DRD3, DRD4, EGFR, EPHX2, GPR35, SMAD3 |
2.41215 |
[BP] GO:0051179 |
None
|
ACHE, ADORA1, ADRA2A, ALOX15, ALOX5, AURKB, AXL, CA1, CA12, CA14, CA2, CA4, CA5A, CA5B, CA6, CA7, CA9, DRD2, DRD3, DRD4, EGFR, F10, FABP3, HSPA1A, MMP12, MMP9, PPARA, SLC6A2, SLC6A3, SRC, XDH |
2.41064 |
[BP] GO:1902532 |
negative regulation of intracellular signal transduction
|
DRD2, DRD3, DUSP3, HSPA1A, IGF1R, MET, MMP9, SRC, XDH |
2.40507 |
[BP] GO:0045834 |
positive regulation of lipid metabolic process
|
FABP3, FLT3, PPARA, SRC, TEK |
2.40435 |
[BP] GO:0046888 |
None
|
ADORA1, ADRA2A, ADRA2C, DRD2 |
2.40435 |
[BP] GO:0051223 |
None
|
ACHE, ADRA2A, ADRA2C, DRD2, DRD3, DRD4, EGFR, HCAR2, MMP12, SMAD3, SRC |
2.40435 |
[BP] GO:1903963 |
None
|
DRD2, DRD3, DRD4 |
2.40435 |
[BP] GO:0044062 |
None
|
ADORA1, DRD2, DRD3 |
2.40435 |
[BP] GO:0050482 |
None
|
DRD2, DRD3, DRD4 |
2.40435 |
[BP] GO:0009404 |
toxin metabolic process
|
CYP1A1, CYP1A2, CYP1B1 |
2.40435 |
[BP] GO:0097746 |
None
|
ADORA1, ADRA2A, ADRA2C, EGFR, EPHX2 |
2.3984 |
[BP] GO:0035296 |
None
|
ADORA1, ADRA2A, ADRA2C, EGFR, EPHX2 |
2.3984 |
[BP] GO:0046486 |
glycerolipid metabolic process
|
ACHE, ALOX15, CSNK2A1, DRD2, EGFR, FABP3, FABP4, MET |
2.38983 |
[BP] GO:0010634 |
positive regulation of epithelial cell migration
|
KDR, MET, MMP9, SRC, TEK |
2.38983 |
[BP] GO:0035625 |
None
|
ADRA2A, ADRA2C |
2.38983 |
[BP] GO:0032811 |
None
|
ADRA2A, ADRA2C |
2.38983 |
[BP] GO:0097176 |
epoxide metabolic process
|
EPHX1, EPHX2 |
2.38983 |
[BP] GO:0032847 |
regulation of cellular pH reduction
|
CA2, CA7 |
2.38983 |
[BP] GO:0051582 |
None
|
DRD2, DRD4 |
2.38983 |
[BP] GO:0018894 |
dibenzo-p-dioxin metabolic process
|
CYP1A1, CYP1A2 |
2.38983 |
[BP] GO:0008283 |
cell proliferation
|
ACHE, AURKB, CYP1A1, EGFR, FLT3, MET, PIM1, SRC, TEK, TYR |
2.37571 |
[BP] GO:0030574 |
collagen catabolic process
|
MMP1, MMP12, MMP2, MMP9 |
2.37435 |
[BP] GO:0051926 |
negative regulation of calcium ion transport
|
ADRA2A, DRD2, DRD4, GPR35 |
2.37435 |
[BP] GO:0051894 |
None
|
KDR, SMAD3, TEK |
2.37006 |
[BP] GO:0071875 |
None
|
ADRA2A, ADRA2C, DRD2 |
2.37006 |
[BP] GO:1903409 |
reactive oxygen species biosynthetic process
|
CYP1A1, CYP1A2, CYP1B1 |
2.37006 |
[BP] GO:0051048 |
None
|
ADORA1, ADRA2A, ADRA2C, DRD2, DRD3, DRD4 |
2.33825 |
[BP] GO:0015718 |
None
|
DRD2, DRD3, DRD4, FABP3, PPARA |
2.29319 |
[BP] GO:0050880 |
None
|
ADORA1, ADRA2A, ADRA2C, EGFR, EPHX2 |
2.29319 |
[BP] GO:0035150 |
None
|
ADORA1, ADRA2A, ADRA2C, EGFR, EPHX2 |
2.27884 |
[BP] GO:0032309 |
None
|
DRD2, DRD3, DRD4 |
2.27261 |
[BP] GO:1903393 |
None
|
KDR, SMAD3, TEK |
2.27261 |
[BP] GO:0001975 |
None
|
DRD2, DRD3, DRD4 |
2.27261 |
[BP] GO:0070201 |
None
|
ACHE, ADRA2A, ADRA2C, DRD2, DRD3, DRD4, EGFR, HCAR2, MMP12, SMAD3, SRC |
2.23845 |
[BP] GO:0071495 |
cellular response to endogenous stimulus
|
ADRA2A, AKR1B1, APEX1, EGFR, FLT3, IGF1R, INSR, MMP2, SMAD3, SRC |
2.23845 |
[BP] GO:0044238 |
primary metabolic process
|
ACHE, ADORA1, AKR1B1, ALOX15, ALOX5, APEX1, AURKB, AXL, CBR1, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, DRD2, DUSP3, EGFR, EPHX2, F10, FABP3, FABP4, FLT3, FUT7, GLO1, HSD17B1, HSD17B2, HSPA1A, IGF1R, INSR, KDR, MET, MMP1, MMP12, MMP2, MMP9, NUAK1, PIM1, PPARA, SMAD3, SRC, TEK, TOP2A, TYR, XDH |
2.23144 |
[BP] GO:1903725 |
regulation of phospholipid metabolic process
|
FABP3, FLT3, SRC, TEK |
2.21988 |
[BP] GO:0007189 |
None
|
ADRA2A, ADRA2C, DRD2, DRD3 |
2.21988 |
[BP] GO:0032412 |
None
|
ADRA2A, DRD2, DRD3, DRD4, GPR35, MMP9 |
2.2112 |
[BP] GO:0001101 |
response to acid chemical
|
AKR1B1, EGFR, FABP3, HSD17B2, KDR, MMP2, SRC |
2.20416 |
[BP] GO:0044243 |
multicellular organismal catabolic process
|
MMP1, MMP12, MMP2, MMP9 |
2.20416 |
[BP] GO:0035624 |
None
|
ADRA2A, ADRA2C |
2.20416 |
[BP] GO:0090325 |
None
|
DRD2, DRD3 |
2.20416 |
[BP] GO:0014060 |
None
|
ADRA2A, ADRA2C |
2.20416 |
[BP] GO:0042321 |
None
|
ADORA1, DRD2 |
2.20416 |
[BP] GO:0016477 |
cell migration
|
AXL, CYP1B1, DRD2, EGFR, FUT7, KDR, MMP1, MMP12, MMP9, SRC, TEK |
2.20316 |
[BP] GO:0016310 |
phosphorylation
|
AURKB, AXL, CSNK2A1, EGFR, FLT3, IGF1R, INSR, KDR, MET, NUAK1, PIM1, SRC, TEK |
2.17229 |
[BP] GO:0022898 |
None
|
ADRA2A, DRD2, DRD3, DRD4, GPR35, MMP9 |
2.16101 |
[BP] GO:0071715 |
None
|
DRD2, DRD3, DRD4 |
2.15446 |
[BP] GO:0007176 |
None
|
ADORA1, ADRA2A, ADRA2C |
2.15446 |
[BP] GO:1901571 |
None
|
DRD2, DRD3, DRD4 |
2.15446 |
[BP] GO:0031100 |
animal organ regeneration
|
AXL, CSNK2A1, EGFR, FLT3 |
2.15026 |
[BP] GO:0048661 |
positive regulation of smooth muscle cell proliferation
|
AKR1B1, EGFR, MMP2, MMP9 |
2.15026 |
[BP] GO:0045931 |
positive regulation of mitotic cell cycle
|
APEX1, CYP1A1, DRD3, DUSP3, INSR |
2.14935 |
[BP] GO:0050730 |
None
|
ADORA1, ADRA2A, ADRA2C, EGFR, FLT3, SRC |
2.13859 |
[BP] GO:0042060 |
None
|
ALOX15, EGFR, PPARA, SMAD3 |
2.13139 |
[BP] GO:0009410 |
None
|
DRD2, DRD3, DRD4, EGFR, SLC6A3 |
2.12548 |
[BP] GO:0043552 |
positive regulation of phosphatidylinositol 3-kinase activity
|
FLT3, SRC, TEK |
2.11929 |
[BP] GO:0042743 |
hydrogen peroxide metabolic process
|
CYP1A1, CYP1A2, EGFR |
2.11929 |
[BP] GO:1900542 |
None
|
ADRA2A, DRD2, DRD3, DRD4, INSR, PPARA |
2.11437 |
[BP] GO:0019932 |
second-messenger-mediated signaling
|
ADRA2A, ADRA2C, DRD2, DRD3, EGFR, KDR |
2.10638 |
[BP] GO:0050714 |
None
|
ACHE, DRD2, EGFR, HCAR2, MMP12, SRC |
2.10638 |
[BP] GO:1901361 |
None
|
CYP19A1, CYP1A1, CYP1A2, CYP2A6, EPHX2, HSPA1A, SLC6A3, XDH |
2.10237 |
[BP] GO:0022617 |
extracellular matrix disassembly
|
MMP1, MMP12, MMP2, MMP9 |
2.09862 |
[BP] GO:0042220 |
None
|
DRD2, DRD3, SLC6A3 |
2.08649 |
[BP] GO:1901890 |
None
|
KDR, SMAD3, TEK |
2.08649 |
[BP] GO:0071276 |
cellular response to cadmium ion
|
CYP1A2, EGFR, MMP9 |
2.08649 |
[BP] GO:0010039 |
response to iron ion
|
CYP1A1, DRD2, SLC6A3 |
2.08649 |
[BP] GO:0035556 |
intracellular signal transduction
|
ADRA2A, ADRA2C, AKR1B1, AXL, CYP1B1, DRD2, DRD3, EGFR, IGF1R, INSR, KDR, MET, NUAK1, SRC, TEK |
2.08475 |
[BP] GO:0009968 |
negative regulation of signal transduction
|
ADRA2A, DRD2, DRD3, DUSP3, EGFR, HSPA1A, IGF1R, MET, MMP12, MMP9, SMAD3, SRC, XDH |
2.08143 |
[BP] GO:0040011 |
locomotion
|
AXL, CYP1B1, DRD2, EGFR, FUT7, KDR, MET, MMP1, MMP12, MMP9, SRC, TEK |
2.07745 |
[BP] GO:0032963 |
collagen metabolic process
|
MMP1, MMP12, MMP2, MMP9 |
2.07358 |
[BP] GO:0032880 |
regulation of protein localization
|
ACHE, ADRA2A, ADRA2C, CSNK2A1, DRD2, DRD3, DRD4, EGFR, HCAR2, MMP12, SMAD3, SRC |
2.07358 |
[BP] GO:0032415 |
None
|
DRD3, DRD4 |
2.07358 |
[BP] GO:0051934 |
None
|
SLC6A2, SLC6A3 |
2.07358 |
[BP] GO:0021984 |
None
|
DRD2, SLC6A3 |
2.07358 |
[BP] GO:0090494 |
None
|
SLC6A2, SLC6A3 |
2.07358 |
[BP] GO:0090493 |
None
|
SLC6A2, SLC6A3 |
2.07358 |
[BP] GO:0051583 |
None
|
SLC6A2, SLC6A3 |
2.07358 |
[BP] GO:2001300 |
lipoxin metabolic process
|
ALOX15, ALOX5 |
2.07358 |
[BP] GO:0044248 |
cellular catabolic process
|
ACHE, AURKB, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, CYP2A6, EPHX1, EPHX2, FABP3, FABP4, HSPA1A, SLC6A3, SRC, XDH |
2.07266 |
[BP] GO:0006140 |
None
|
ADRA2A, DRD2, DRD3, DRD4, INSR, PPARA |
2.07213 |
[BP] GO:0098801 |
None
|
ADORA1, DRD2, DRD3 |
2.06629 |
[BP] GO:2000273 |
None
|
ADORA1, ADRA2A, ADRA2C |
2.06629 |
[BP] GO:0048732 |
gland development
|
CSNK2A1, CYP19A1, EGFR, INSR, SMAD3, TYR |
2.06629 |
[BP] GO:0032409 |
None
|
ADRA2A, DRD2, DRD3, DRD4, GPR35, MMP9 |
2.06629 |
[BP] GO:0045936 |
None
|
ADRA2A, DRD2, DRD3, DRD4, DUSP3, FABP4, IGF1R, PPARA, XDH |
2.0646 |
[BP] GO:1901888 |
regulation of cell junction assembly
|
KDR, SMAD3, SRC, TEK |
2.06393 |
[BP] GO:0010563 |
None
|
ADRA2A, DRD2, DRD3, DRD4, DUSP3, FABP4, IGF1R, PPARA, XDH |
2.06107 |
[BP] GO:0060255 |
regulation of macromolecule metabolic process
|
ACHE, ADORA1, ADORA3, ADRA2A, ADRA2C, ALOX15, APEX1, AURKB, CA9, CSNK2A1, CYP1A2, CYP1B1, DRD2, DRD3, DRD4, DUSP3, EGFR, EPHX2, FABP4, FLT3, GLO1, HSPA1A, IGF1R, INSR, KDR, MET, MMP12, MMP9, NUAK1, PIM1, PPARA, SMAD3, SRC, TEK, TOP2A, XDH |
2.03729 |
[BP] GO:0071902 |
positive regulation of protein serine/threonine kinase activity
|
ADORA1, ADRA2A, DRD4, EGFR, FLT3, INSR, SRC |
2.03665 |
[BP] GO:0090218 |
positive regulation of lipid kinase activity
|
FLT3, SRC, TEK |
2.03408 |
[BP] GO:0010907 |
None
|
INSR, PPARA, SRC |
2.03408 |
[BP] GO:1901575 |
None
|
ACHE, ADORA1, AURKB, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A6, EPHX2, FABP3, FABP4, FUT7, HSPA1A, SLC6A3, XDH |
2.03066 |
[BP] GO:0009892 |
negative regulation of metabolic process
|
ADORA1, ADRA2A, APEX1, AURKB, CSNK2A1, DRD2, DRD3, DRD4, DUSP3, EGFR, FABP4, HCAR2, HSPA1A, IGF1R, KDR, MET, MMP12, MMP9, PPARA, SMAD3, SRC, XDH |
2.01881 |
[BP] GO:0044093 |
positive regulation of molecular function
|
ADORA1, ADRA2A, ADRA2C, AURKB, DRD2, DRD4, EGFR, FLT3, HSPA1A, INSR, MET, MMP9, SMAD3, SRC, TEK, XDH |
2.01303 |
[BP] GO:0051704 |
multi-organism process
|
ADRA2C, AXL, CYP1A1, DRD3, DRD4, EGFR, HSPA1A, INSR, KDR, MET, MMP1, MMP12, SMAD3, SRC |
2.0082 |
[BP] GO:0032268 |
regulation of cellular protein metabolic process
|
ADORA1, ADRA2A, ADRA2C, ALOX15, CSNK2A1, DRD2, DRD4, DUSP3, EGFR, FABP4, FLT3, HSPA1A, IGF1R, INSR, KDR, MMP9, NUAK1, SMAD3, SRC, TEK, XDH |
2.00777 |
[BP] GO:1903532 |
None
|
ACHE, CYP19A1, DRD2, EGFR, HCAR2, MMP12, SRC |
2.00777 |
[BP] GO:0003008 |
None
|
ADORA1, ADRA2A, ADRA2C, AKR1B1, CYP1B1, DRD2, DRD3, EGFR, EPHX2, INSR, SLC6A3, SRC, TEK, TYR |
2.00777 |
[CC] GO:0031226 |
intrinsic component of plasma membrane
|
ADORA1, ADORA3, ADRA2A, ADRA2C, AXL, CA4, DRD2, DRD3, DRD4, F10, FLT3, GPR35, IGF1R, INSR, KDR, MET, SLC6A2, SLC6A3, TEK |
4.25175 |
[CC] GO:0044459 |
plasma membrane part
|
ADORA1, ADORA3, ADRA2A, ADRA2C, ALOX15, AXL, CA2, CA4, CA9, DRD2, DRD3, DRD4, DUSP3, EGFR, F10, FLT3, GPR35, IGF1R, INSR, KDR, MET, SLC6A2, SLC6A3, SRC, TEK |
3.81383 |
[CC] GO:0005886 |
plasma membrane
|
ACHE, ADORA1, ADORA3, ADRA2A, ADRA2C, ALOX15, AXL, CA12, CA14, CA2, CA4, CA9, CSNK2A1, DRD2, DRD3, DRD4, EGFR, F10, FLT3, GLO1, GPR35, HCAR2, IGF1R, INSR, KDR, MET, MMP2, PIM1, SLC6A2, SLC6A3, SMAD3, SRC, TEK |
3.58514 |
[CC] GO:0016323 |
basolateral plasma membrane
|
ADORA1, ADRA2A, CA2, CA4, CA9, EGFR, TEK |
3.42831 |
[CC] GO:0005887 |
integral component of plasma membrane
|
ADORA1, ADORA3, ADRA2A, ADRA2C, AXL, DRD2, DRD3, DRD4, FLT3, GPR35, IGF1R, INSR, KDR, MET, SLC6A2, SLC6A3, TEK |
3.41321 |
[CC] GO:0016020 |
membrane
|
ACHE, ADORA1, ADORA3, ADRA2A, ADRA2C, ALOX15, ALOX5, AXL, CA12, CA14, CA2, CA4, CA9, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, DRD2, DRD3, DRD4, EGFR, EPHX1, F10, FLT3, FUT7, GLO1, GPR35, HCAR2, HSD17B2, IGF1R, INSR, KDR, MET, MMP2, PIM1, SLC6A2, SLC6A3, SMAD3, SRC, TEK, TYR |
2.76762 |
[CC] GO:0045121 |
membrane raft
|
EGFR, INSR, KDR, SLC6A2, SLC6A3, SRC, TEK |
2.4065 |
[CC] GO:0098857 |
membrane microdomain
|
EGFR, INSR, KDR, SLC6A2, SLC6A3, SRC, TEK |
2.40031 |
[CC] GO:0044425 |
membrane part
|
ACHE, ADORA1, ADORA3, ADRA2A, ADRA2C, ALOX15, AXL, CA12, CA14, CA2, CA4, CA9, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, DRD2, DRD3, DRD4, DUSP3, EGFR, EPHX1, F10, FLT3, FUT7, GPR35, HCAR2, HSD17B2, IGF1R, INSR, KDR, MET, SLC6A2, SLC6A3, SRC, TEK, TYR |
2.38031 |
[CC] GO:0098589 |
membrane region
|
EGFR, INSR, KDR, SLC6A2, SLC6A3, SRC, TEK |
2.01881 |
[MF] GO:0004089 |
carbonate dehydratase activity
|
CA1, CA12, CA14, CA2, CA4, CA5A, CA5B, CA6, CA7, CA9 |
17.1644 |
[MF] GO:0046914 |
transition metal ion binding
|
ALOX15, ALOX5, CA1, CA12, CA2, CA4, CA5A, CA5B, CA6, CA7, CA9, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, GLO1, MMP1, MMP12, MMP2, MMP9, PIM1, PPARA, SMAD3, TYR, XDH |
12.5323 |
[MF] GO:0043167 |
ion binding
|
ACHE, ALOX15, ALOX5, APEX1, AURKB, AXL, CA1, CA12, CA14, CA2, CA4, CA5A, CA5B, CA6, CA7, CA9, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, DRD2, DRD3, DRD4, EGFR, EPHX2, F10, FABP3, FABP4, FLT3, GLO1, HSD17B1, HSPA1A, IGF1R, INSR, KDR, MET, MMP1, MMP12, MMP2, MMP9, NUAK1, PIM1, PPARA, SLC6A2, SLC6A3, SMAD3, SRC, TEK, TOP2A, TYR, XDH |
12.3287 |
[MF] GO:0003824 |
catalytic activity
|
ACHE, ADORA1, AKR1B1, ALOX15, ALOX5, APEX1, AURKB, AXL, CA1, CA12, CA14, CA2, CA4, CA5A, CA5B, CA6, CA7, CA9, CBR1, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, DUSP3, EGFR, EPHX1, EPHX2, F10, FLT3, FUT7, GLO1, HSD17B1, HSD17B2, HSPA1A, IGF1R, INSR, KDR, MET, MMP1, MMP12, MMP2, MMP9, NUAK1, PIM1, SRC, TEK, TOP2A, TYR, XDH |
11.3733 |
[MF] GO:0016835 |
carbon-oxygen lyase activity
|
APEX1, CA1, CA12, CA14, CA2, CA4, CA5A, CA5B, CA6, CA7, CA9 |
11.3346 |
[MF] GO:0016836 |
hydro-lyase activity
|
CA1, CA12, CA14, CA2, CA4, CA5A, CA5B, CA6, CA7, CA9 |
11.0669 |
[MF] GO:0016829 |
lyase activity
|
APEX1, CA1, CA12, CA14, CA2, CA4, CA5A, CA5B, CA6, CA7, CA9, GLO1 |
8.75042 |
[MF] GO:0043169 |
cation binding
|
ACHE, ALOX15, ALOX5, APEX1, AURKB, CA1, CA12, CA14, CA2, CA4, CA5A, CA5B, CA6, CA7, CA9, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, DRD2, DRD3, DRD4, EPHX2, F10, GLO1, MMP1, MMP12, MMP2, MMP9, NUAK1, PIM1, PPARA, SLC6A2, SLC6A3, SMAD3, TOP2A, TYR, XDH |
7.94247 |
[MF] GO:0008144 |
drug binding
|
ACHE, AURKB, AXL, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, DRD2, DRD3, DRD4, EGFR, FLT3, HSPA1A, IGF1R, INSR, KDR, MET, NUAK1, PIM1, PPARA, SLC6A3, SRC, TEK, TOP2A |
7.65238 |
[MF] GO:0004714 |
transmembrane receptor protein tyrosine kinase activity
|
AXL, EGFR, FLT3, IGF1R, INSR, KDR, MET, TEK |
7.51566 |
[MF] GO:1901338 |
None
|
ADRA2A, ADRA2C, DRD2, DRD3, DRD4, SLC6A3 |
7.4365 |
[MF] GO:0019199 |
transmembrane receptor protein kinase activity
|
AXL, EGFR, FLT3, IGF1R, INSR, KDR, MET, TEK |
6.80638 |
[MF] GO:0016712 |
oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6 |
6.79071 |
[MF] GO:0046872 |
metal ion binding
|
ALOX15, ALOX5, APEX1, AURKB, CA1, CA12, CA14, CA2, CA4, CA5A, CA5B, CA6, CA7, CA9, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, EPHX2, F10, GLO1, MMP1, MMP12, MMP2, MMP9, NUAK1, PIM1, PPARA, SLC6A2, SLC6A3, SMAD3, TOP2A, TYR, XDH |
5.90356 |
[MF] GO:0005506 |
iron ion binding
|
ALOX15, ALOX5, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, XDH |
5.8886 |
[MF] GO:0008270 |
zinc ion binding
|
CA1, CA12, CA2, CA4, CA5A, CA5B, CA6, CA7, CA9, GLO1, MMP1, MMP12, MMP2, MMP9, PPARA, SMAD3 |
5.47644 |
[MF] GO:0004713 |
protein tyrosine kinase activity
|
AXL, EGFR, FLT3, IGF1R, INSR, KDR, MET, SRC, TEK |
5.45339 |
[MF] GO:0070330 |
aromatase activity
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13 |
5.38717 |
[MF] GO:0016491 |
oxidoreductase activity
|
AKR1B1, ALOX15, ALOX5, APEX1, CBR1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, HSD17B1, HSD17B2, TYR, XDH |
5.3001 |
[MF] GO:0044877 |
macromolecular complex binding
|
ACHE, ADORA1, ADRA2A, APEX1, CSNK2A1, EGFR, FLT3, IGF1R, INSR, KDR, MMP12, MMP9, PIM1, PPARA, SLC6A3, SMAD3, SRC |
5.19134 |
[MF] GO:0004497 |
monooxygenase activity
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, TYR |
5.04718 |
[MF] GO:0032403 |
protein complex binding
|
ACHE, ADORA1, ADRA2A, APEX1, EGFR, FLT3, IGF1R, INSR, KDR, MMP12, MMP9, PPARA, SLC6A3, SMAD3, SRC |
4.8693 |
[MF] GO:0035240 |
None
|
DRD2, DRD3, DRD4, SLC6A3 |
4.69647 |
[MF] GO:0004672 |
protein kinase activity
|
AURKB, AXL, CSNK2A1, EGFR, FLT3, IGF1R, INSR, KDR, MET, NUAK1, PIM1, SRC, TEK |
4.25549 |
[MF] GO:0020037 |
heme binding
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, SRC |
4.25549 |
[MF] GO:0019825 |
oxygen binding
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13 |
4.09899 |
[MF] GO:0046906 |
tetrapyrrole binding
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, SRC |
4.09469 |
[MF] GO:0038023 |
signaling receptor activity
|
ADORA1, ADORA3, ADRA2A, ADRA2C, AXL, DRD2, DRD3, DRD4, EGFR, FLT3, GPR35, HCAR2, IGF1R, INSR, KDR, MET, PPARA, TEK |
4.04545 |
[MF] GO:0099600 |
transmembrane receptor activity
|
ADORA1, ADORA3, ADRA2A, ADRA2C, AXL, DRD2, DRD3, DRD4, EGFR, FLT3, GPR35, HCAR2, IGF1R, INSR, KDR, MET, TEK |
3.93735 |
[MF] GO:0004888 |
transmembrane signaling receptor activity
|
ADORA1, ADORA3, ADRA2A, ADRA2C, AXL, DRD2, DRD3, DRD4, EGFR, FLT3, GPR35, HCAR2, IGF1R, INSR, KDR, MET, TEK |
3.93735 |
[MF] GO:0016705 |
oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, TYR |
3.81673 |
[MF] GO:0051379 |
None
|
ADRA2A, ADRA2C, DRD4 |
3.57075 |
[MF] GO:0001591 |
None
|
DRD2, DRD3, DRD4 |
3.57075 |
[MF] GO:0016773 |
phosphotransferase activity, alcohol group as acceptor
|
AURKB, AXL, CSNK2A1, EGFR, FLT3, IGF1R, INSR, KDR, MET, NUAK1, PIM1, SRC, TEK |
3.57075 |
[MF] GO:0004871 |
signal transducer activity
|
ADORA1, ADORA3, ADRA2A, ADRA2C, AXL, DRD2, DRD3, DRD4, EGFR, FLT3, GPR35, HCAR2, IGF1R, INSR, KDR, MET, PPARA, SMAD3, TEK |
3.47329 |
[MF] GO:0004872 |
receptor activity
|
ADORA1, ADORA3, ADRA2A, ADRA2C, AXL, DRD2, DRD3, DRD4, EGFR, FLT3, GPR35, HCAR2, IGF1R, INSR, KDR, MET, PPARA, TEK |
3.45554 |
[MF] GO:0016803 |
ether hydrolase activity
|
ALOX15, EPHX1, EPHX2 |
3.44194 |
[MF] GO:0004716 |
signal transducer, downstream of receptor, with protein tyrosine kinase activity
|
EGFR, INSR, KDR |
3.44194 |
[MF] GO:0060089 |
molecular transducer activity
|
ADORA1, ADORA3, ADRA2A, ADRA2C, AXL, DRD2, DRD3, DRD4, EGFR, FLT3, GPR35, HCAR2, IGF1R, INSR, KDR, MET, PPARA, TEK |
3.3103 |
[MF] GO:0070405 |
ammonium ion binding
|
ACHE, DRD2, DRD3, DRD4, SLC6A3 |
3.28433 |
[MF] GO:0008395 |
steroid hydroxylase activity
|
CYP19A1, CYP1A1, CYP2A13, CYP2A6 |
3.26923 |
[MF] GO:0016301 |
kinase activity
|
AURKB, AXL, CSNK2A1, EGFR, FLT3, IGF1R, INSR, KDR, MET, NUAK1, PIM1, SRC, TEK |
3.25423 |
[MF] GO:0004952 |
None
|
DRD2, DRD3, DRD4 |
3.11745 |
[MF] GO:0016801 |
None
|
ALOX15, EPHX1, EPHX2 |
3.11745 |
[MF] GO:0042562 |
hormone binding
|
ACHE, EGFR, HSD17B1, IGF1R, INSR |
3.02452 |
[MF] GO:0008389 |
None
|
CYP2A13, CYP2A6 |
2.9976 |
[MF] GO:0004935 |
None
|
ADRA2A, ADRA2C, DRD2 |
2.78605 |
[MF] GO:0042802 |
identical protein binding
|
ACHE, ADRA2A, ADRA2C, CSNK2A1, DRD2, DRD4, EGFR, EPHX2, FLT3, IGF1R, KDR, MET, MMP9, SMAD3, TOP2A, TYR, XDH |
2.73844 |
[MF] GO:0016772 |
transferase activity, transferring phosphorus-containing groups
|
AURKB, AXL, CSNK2A1, EGFR, FLT3, IGF1R, INSR, KDR, MET, NUAK1, PIM1, SRC, TEK |
2.63312 |
[MF] GO:0004938 |
None
|
ADRA2A, ADRA2C |
2.62163 |
[MF] GO:0005330 |
None
|
SLC6A2, SLC6A3 |
2.62163 |
[MF] GO:0048037 |
cofactor binding
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, HSD17B1, SRC, XDH |
2.59423 |
[MF] GO:0046982 |
protein heterodimerization activity
|
ADORA1, ADRA2A, ADRA2C, AXL, DRD2, EGFR, SMAD3, TOP2A, TYR |
2.51407 |
[MF] GO:0005518 |
collagen binding
|
ACHE, MMP12, MMP9, SMAD3 |
2.40435 |
[MF] GO:0032795 |
None
|
ADORA1, ADRA2A |
2.38983 |
[MF] GO:0019838 |
growth factor binding
|
EGFR, IGF1R, INSR, KDR, TEK |
2.32228 |
[MF] GO:0016614 |
oxidoreductase activity, acting on CH-OH group of donors
|
AKR1B1, CBR1, HSD17B1, HSD17B2, XDH |
2.23845 |
[MF] GO:0005524 |
ATP binding
|
AURKB, AXL, CSNK2A1, EGFR, FLT3, HSPA1A, IGF1R, INSR, KDR, MET, NUAK1, PIM1, SRC, TEK, TOP2A |
2.21888 |
[MF] GO:0043559 |
insulin binding
|
IGF1R, INSR |
2.20416 |
[MF] GO:0051380 |
None
|
ADRA2A, DRD4 |
2.20416 |
[MF] GO:0036094 |
small molecule binding
|
ADORA1, AURKB, AXL, CSNK2A1, EGFR, FABP3, FABP4, FLT3, HSD17B1, HSPA1A, IGF1R, INSR, KDR, MET, NUAK1, PIM1, SRC, TEK, TOP2A, XDH |
2.18663 |
[MF] GO:0043548 |
phosphatidylinositol 3-kinase binding
|
AXL, IGF1R, INSR |
2.15446 |
[MF] GO:0032559 |
adenyl ribonucleotide binding
|
AURKB, AXL, CSNK2A1, EGFR, FLT3, HSPA1A, IGF1R, INSR, KDR, MET, NUAK1, PIM1, SRC, TEK, TOP2A |
2.13034 |
[MF] GO:0030554 |
adenyl nucleotide binding
|
AURKB, AXL, CSNK2A1, EGFR, FLT3, HSPA1A, IGF1R, INSR, KDR, MET, NUAK1, PIM1, SRC, TEK, TOP2A |
2.1059 |
[MF] GO:0005329 |
None
|
SLC6A2, SLC6A3 |
2.07358 |
[MF] GO:0004936 |
None
|
ADRA2A, ADRA2C |
2.07358 |
[MF] GO:0004064 |
arylesterase activity
|
CA1, CA2 |
2.07358 |
[MF] GO:0004301 |
None
|
EPHX1, EPHX2 |
2.07358 |
[MF] GO:0005102 |
receptor binding
|
ADORA1, ADRA2A, ADRA2C, DRD2, DRD3, EGFR, EPHX2, FLT3, HSPA1A, IGF1R, INSR, KDR, SLC6A3, SMAD3, SRC |
2.05353 |